Abstract:Food protein-derived peptides have been recognised as an important category of functional food materials, which exert various bioactivities and possible health-promoting impacts in human beyond their traditional nutritional values (Hern andez-Ledesma & Hsieh, 2017; Aguilar et al., 2019). Bioactive peptides could be produced by food processing processes such as fermentation, etc., from longer polypeptides or proteins. A growing body of scientific evidence has demonstrated that peptides bearing characteristic sequences can prevent various lifestyle-related diseases such as diabetic, hypertension and atherosclerosis. In addition to bioactivities, current peptide researches focus on physiological stability in the gastrointestinal tract as well as intestinal absorption to understand the bioaccessibility and bioavailability of bioactive peptides (Matsui, 2018). This special issue summarises current understandings on bioaccessibility and bioavailability of food protein-derived bioactive peptides, which also include a review on clinical aspects of bioactive peptides, as well as future challenges and ongoing research needs in the field of peptide science. Written by world renowned leading scientists, it is hoped that the knowledge and insights gained from this special issue will lead to further development in the rapidly growing field of bioactive peptides from food proteins. Epidemiological studies have revealed that consumption of milk and fermented dairy products is inversely associated with elevated blood pressure and with many of the risk factors of the metabolic syndrome and combats against hypertension and vascular dysfunction. An overview of the potential blood pressure lowering components present in dairy products with a special focus on casein-derived tripeptides was described. Dairy proteinderived bioactive peptides (DBPs) have potential benefits for human health. However, their transport mechanisms and bioavailability from intestinal lumen to bloodstream are not well understood. Understanding of their transport mechanisms across the intestinal membrane (peptide transporter 1, paracellular route, transcytosis and passive transcellular diffusion) and the bioavailability of DBPs in animal and human studies were highlighted. Current research on in vitro and in vivo absorption of these compounds and factors that play a key role in this process provides better understanding of the in vitro and in vivo bioavailability and bioaccessibility of peptides. Peptides display diverse structural features because of their varied amino acid compositions. The structural diversity often imparts them complex physiological functions or possible health-beneficial effects. Some small peptides (di-/tripeptides) exert preventive effects against conditions such as hypertension, hypercholesterolaemia and atherosclerosis. Despite their health benefits, a limited understanding of peptide absorption may hinder their extensive application. Therefore, in vitro and in vivo findings on the intestinal absorption of small peptides and potential factors affecting their absorption were emphasised. Bioactive peptides can be protected from the gastrointestinal environment by microencapsulation. Microcapsules obtained by spray drying using maltodextrin/gun arabic in optimal formula preserved the a-glucosidase, a-amylase and dipeptidyl peptidase-IV inhibitory activity of P. lunatus peptides after in vitro gastrointestinal digestion. Lupine (Lupinus angustifolius L.) protein (in wholemeal and protein isolates) was biodegraded using Pediococcus acidilactici in submerged and solid-state fermentation conditions. Biodegradation improved the antioxidant properties, modulated the antimicrobial properties and led to higher in vitro and in vivo digestibility and functionality of the lupine in treated rats. Diabetes mellitus is a complex disorder caused by insufficient insulin production or insulin resistance. It was to update the state-of-the-art regarding the origin, structural characteristics, action and potential mechanisms of bioactive peptides on the key enzymes and proteins, i.e., a-amylase, a-glucosidase. Epidemiological studies have shown that soy consumption is associated with lower incidence of various diseases, including cancer. Over the past decades, soy proteins and derived peptides have been considered as potential preventive agent against the initiation, promotion and progression of cancer. Specifically emphasising This Editorial should have been published in Special Issue 54:6 (‘Bioaccessibility and bio-availability of food derived bioactive peptides’) but, due to a production error, was published in issue 54:7 instead. The publisher apologizes for this error and the inconvenience caused. International Journal of Food Science and Technology 2019, 54, 2319–2320

Recent Advances in the Health Benefits of Pea Protein (pisum Sativum): Bioactive Peptides and the Interaction with the Gut Microbiome

Recent progress in the fabrication of advanced emulsions with pea proteins and their application in the food industry

Bioactive Peptides of Plant Origin: Distribution, Functionality, and Evidence of Benefits in Food and Health

The Health Benefits, Functional Properties, Modifications, and Applications of Pea (pisum Sativuml.) Protein: Current Status, Challenges, and Perspectives

The Alteration of Gut Microbiota by Bioactive Peptides: a Review

Edible plant Jiaosu: manufacturing, bioactive compounds, potential health benefits, and safety aspects

Production and Functionality of Food-derived bioactive peptides: A review.

Recent Advances in Exploring and Exploiting Soybean Functional Peptides-a Review.

A Comprehensive Review of Pea (Pisum sativum L.): Chemical Composition, Processing, Health Benefits, and Food Applications

Plant-based proteins: advances in their sources, digestive profiles in vitro and potential health benefits

Exploiting the Interactions Between Plant Proteins and Gut Microbiota to Promote Intestinal Health

Current understanding of bioaccessibility and bioavailability of food‐derived bioactive peptides

Interplay of Food-Derived Bioactive Peptides with Gut Microbiota: Implications for Health and Disease Management

Recent Advancements in Novel Bioactive Peptides and Protein Hydrolysates Isolated from Different Medicinal Plants Along with Their Applications in Food and Pharmaceutical Industries

Health benefits of bioactive peptides produced from muscle proteins: Antioxidant, anti-cancer, and anti-diabetic activities

Nutritional composition, health benefits and bio-active compounds of chickpea (Cicer arietinum L.)

Dietary-Nutraceutical Properties of Oat Protein and Peptides

The Current Situation of Pea Protein and Its Application in the Food Industry

Emerging production techniques and potential health promoting properties of plant and animal protein-derived bioactive peptides

A Review of Bioactive Compound Effects from Primary Legume Protein Sources in Human and Animal Health

Pulse Proteins and Their Hydrolysates: A Comprehensive Review of Their Beneficial Effects on Metabolic Syndrome and the Gut Microbiome